During the past decade, Hospital Universiti Sains Malaysia conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 7 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 6 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universiti Sains Malaysia" #1 sponsor was "Universiti Sains Malaysia" with 22 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Ministry of Health, Malaysia" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Agennix" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universiti Sains Malaysia" #1 collaborator was "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Ambu A/S" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "International Islamic University Malaysia" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universiti Sains Malaysia" are "Crohn Disease" (2 trials), "Diabetic Nephropathies" (2 trials), "Difficult Intubation" (2 trials), "Erosive Esophagitis" (2 trials) and "General Anaesthesia" (2 trials). Many other conditions were trialed in "Hospital Universiti Sains Malaysia" in a lesser frequency.

Most popular intervention types in "Hospital Universiti Sains Malaysia" are "Drug" (28 trials), "Other" (8 trials), "Procedure" (4 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BI 685509" (2 trials), "Exercise" (2 trials), "Lansoprazole" (2 trials) and "Lansoprazole Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universiti Sains Malaysia" are 42 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universiti Sains Malaysia". 1 are not yet recruiting, 12 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Hospital Universiti Sains Malaysia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universiti Sains Malaysia, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".